Gynecomastia and hypertension in a patient treated with posaconazole

George R. Thompson, Prasanth N. Surampudi, Alex Odermatt

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.

Original languageEnglish (US)
Pages (from-to)3158-3161
Number of pages4
JournalClinical Case Reports
Issue number12
StatePublished - Dec 2020
Externally publishedYes


  • 11beta-hydroxylase
  • adverse drug effect
  • estradiol
  • gynecomastia
  • hypertension
  • hypokalemia
  • posaconazole

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Gynecomastia and hypertension in a patient treated with posaconazole'. Together they form a unique fingerprint.

Cite this